Clinical Trial Update: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating autologous stem cell transplantation for progressive systemic sclerosis with cardiac involvement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Scleroderma, Cardiac Involvement | Phase 2 | Status: COMPLETED